基本资料 投资组合 财务数据 基金公告
广发生物科技指数人民币(QDII)C(016470) |
净值：
1.6420
|
日增长率：
-2.20%
|
累计净值：1.6420 | 2026-09-23 |
|
|
||||
| 股票代码 | 股票简称 | 持股数量(股) | 持股市值(元) | 占基金净值比(%) |
| VRTX | 福泰制药 | 4,384.00 | 14,831,853.92 | 6.98 |
| VRTX | 福泰制药 | 4,384.00 | 14,831,853.92 | 6.98 |
| AMGN | 安进 | 5,611.00 | 13,838,763.40 | 6.52 |
| AMGN | 安进 | 5,611.00 | 13,838,763.40 | 6.52 |
| GILD | 吉利德科学 | 14,617.00 | 12,577,769.26 | 5.92 |
| GILD | 吉利德科学 | 14,617.00 | 12,577,769.26 | 5.92 |
| REGN | 再生元制药 | 2,200.00 | 9,343,110.89 | 4.40 |
| REGN | 再生元制药 | 2,200.00 | 9,343,110.89 | 4.40 |
| ALNY | Alnylam Pharmaceuticals Inc | 2,807.00 | 5,755,150.63 | 2.71 |
| ALNY | Alnylam Pharmaceuticals Inc | 2,807.00 | 5,755,150.63 | 2.71 |
| RVMD | Revolution Medicines Inc | 4,195.00 | 5,350,912.75 | 2.52 |
| RVMD | Revolution Medicines Inc | 4,195.00 | 5,350,912.75 | 2.52 |
| BIIB | 生化基因 | 2,917.00 | 4,292,549.43 | 2.02 |
| BIIB | 生化基因 | 2,917.00 | 4,292,549.43 | 2.02 |
| MRNA | Moderna Inc | 7,839.00 | 3,738,946.88 | 1.76 |
| MRNA | Moderna Inc | 7,839.00 | 3,738,946.88 | 1.76 |
| RPRX | Royalty Pharma plc-A | 9,065.00 | 3,461,807.13 | 1.63 |
| RPRX | Royalty Pharma plc-A | 9,065.00 | 3,461,807.13 | 1.63 |
| ARGX | argenx SE ADR | 546.00 | 3,450,145.99 | 1.62 |
| ARGX | argenx SE ADR | 546.00 | 3,450,145.99 | 1.62 |
| 报告期 | 股票占净比(%) | 债券占净比(%) | 现金占净比(%) | 净资产(元) |
| 2026-06-30 | 85.24 | - | 6.84 | 212,378,914.48 |
| 2026-03-31 | 84.93 | - | 6.22 | 216,164,128.25 |
| 2025-12-31 | 77.88 | - | 10.39 | 206,327,611.27 |
| 2025-09-30 | 80.39 | - | 7.10 | 179,555,484.90 |
| 2025-06-30 | 80.14 | - | 7.05 | 191,910,562.78 |
微信公众号
证券之星APP
